To conclude, our results demonstrate that dysfunctional regulation of ASPP1 (PPP1R13B mRNA) expression is frequently observed in AML, which associates with inferior therapy responses and survival outcomes. This evidence concerns the gene PPP1R13B and acute myeloid leukemia.